LBA57 Neoadjuvant nivolumab (N) + chemotherapy (C) in the phase III CheckMate 816 study: 3-y results by tumor PD-L1 expression

著者: M. Provencio Pulla, Patrick M. Forde, J.D. Spicer, C. Wang, Shun Lu, Tetsuya Mitsudomi, Mark M. Awad, Enriqueta Felip, Stephen Broderick, Steven Swanson, Julie R. Brahmer, Keith M. Kerr, G. Saylors, Fumihiro Tanaka, K-N. Chen, Mia Tran, J.L. Cai, Javed Mahmood, S. Meadows–Shropshire, Nicolas Girard - Annals of Oncology 2023 被引用: 18